Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by RazeKreationson Sep 02, 2021 3:05pm
162 Views
Post# 33804274

Market is predicted to improve to the upside

Market is predicted to improve to the upsideFrom BNN Bloomberg MARKET OUTLOOK: Markets continue to hit all-time highs as the economic backdrop continues to show improvement. What investors may feel but are not fully aware of, is that under the surface, the market has been experiencing a correction. When examining market breadth data along with broad stock participation, many companies share prices peaked in April or May and have been sideways to down since. The technical indicators that we follow started to show some sign of underlying market breadth improvements three weeks ago. We continue to see more of these indicators showing positive changes and we are now on the cusp of seeing most turn positive again. This would mean broad based market participation where not just the largest stocks perform but all market capitalization companies would start to see share price improvements.
<< Previous
Bullboard Posts
Next >>